M. S. Hassan and A. M. Jawad, “Assessment of Pathological Response to Neoadjuvant Therapy: Comparison Between Pertuzumab-Based and Non-Pertuzumab Protocols in HER2-Positive Breast Cancer”, MECOJ, vol. 2, no. 3, pp. 1–9, Jul. 2026, doi: 10.61706/MECOJ160229.